Last $462.77 MXN
Change Today 0.00 / 0.00%
Volume 0.0
PFE* On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 4:09 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for pfizer inc (PFE*)

Year over year, Pfizer Inc. has been able to grow their bottom line from $14.6B USD to $22.0B USD despite falling revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
Revenues65,165.061,035.054,657.051,584.0
TOTAL REVENUES65,165.061,035.054,657.051,584.0
Cost of Goods Sold14,056.011,700.09,533.09,239.0
GROSS PROFIT51,109.049,335.045,124.042,345.0
Selling General & Admin Expenses, Total18,746.017,484.015,021.014,191.0
R&D Expenses9,431.08,004.06,705.06,551.0
Depreciation & Amortization, Total5,364.05,465.05,109.04,599.0
OTHER OPERATING EXPENSES, TOTAL33,541.030,953.026,835.025,341.0
OPERATING INCOME17,568.018,382.018,289.017,004.0
Interest Expense-1,797.0-1,681.0-1,522.0-1,414.0
Interest and Investment Income400.0456.0382.0403.0
NET INTEREST EXPENSE-1,397.0-1,225.0-1,140.0-1,011.0
Currency Exchange Gains (Loss)---264.0899.0-5.0
Other Non-Operating Income (Expenses)726.0472.0-228.0395.0
EBT, EXCLUDING UNUSUAL ITEMS16,897.017,365.017,820.016,383.0
Merger & Restructuring Charges-3,926.0-4,415.0-2,775.0-1,704.0
Gain (Loss) on Sale of Investments141.0253.0-376.0-79.0
Gain (Loss) on Sale of Assets102.0--22.0697.0
Other Unusual Items, Total-3,743.0-1,722.0-3,449.0419.0
Legal Settlements-1,723.0-784.0-2,220.01,307.0
Other Unusual Items-18.0-104.0-394.0-85.0
EBT, INCLUDING UNUSUAL ITEMS9,471.011,481.011,242.015,716.0
Income Tax Expense1,153.03,621.02,221.04,306.0
Minority Interest in Earnings-31.0-40.0-28.0-69.0
Earnings from Continuing Operations8,318.07,860.09,021.011,410.0
EARNINGS FROM DISCOUNTINUED OPERATIONS-30.02,189.05,577.010,662.0
NET INCOME8,257.010,009.014,570.022,003.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS8,255.010,007.014,568.022,001.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS8,285.07,818.08,991.011,339.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE*:MM $462.77 MXN 0.00

PFE* Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $166.90 USD +0.64
Bayer AG €114.97 EUR +0.112
Gilead Sciences Inc $96.68 USD +2.89
Novartis AG SFr.92.95 CHF +0.60
Procter & Gamble Co/The $92.86 USD -0.60
View Industry Companies
 

Industry Analysis

PFE*

Industry Average

Valuation PFE* Industry Range
Price/Earnings 19.6x
Price/Sales 4.0x
Price/Book 2.6x
Price/Cash Flow 13.6x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.